Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy

L. Mortara; E. Balza; A. Bruno; A. Poggi; P. Orecchia; B. Carnemolla

doi:10.3389/fimmu.2018.02905

Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy

L. Mortara, E. Balza, A. Bruno, A. Poggi, P. Orecchia, B. Carnemolla

IRCCS Multimedica

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2905
Number of pages	1
Journal	Frontiers in Immunology
Volume	9
DOIs	https://doi.org/10.3389/fimmu.2018.02905
Publication status	Published - 2018

Access to Document

10.3389/fimmu.2018.02905

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059930034&doi=10.3389%2ffimmu.2018.02905&partnerID=40&md5=06eb8c850393200219bf53871645b644

Cite this

@article{83d94da935064b8b8955b82bbbb6dc9b,

title = "Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy",

author = "L. Mortara and E. Balza and A. Bruno and A. Poggi and P. Orecchia and B. Carnemolla",

note = "cited By 0",

year = "2018",

doi = "10.3389/fimmu.2018.02905",

language = "Non definita",

volume = "9",

pages = "2905",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy

AU - Mortara, L.

AU - Balza, E.

AU - Bruno, A.

AU - Poggi, A.

AU - Orecchia, P.

AU - Carnemolla, B.

N1 - cited By 0

PY - 2018

Y1 - 2018

U2 - 10.3389/fimmu.2018.02905

DO - 10.3389/fimmu.2018.02905

M3 - Articolo

SN - 1664-3224

VL - 9

SP - 2905

JO - Frontiers in Immunology

JF - Frontiers in Immunology

ER -